Offer - Urjas Oil for just ₹ 1 X
Mabtas Ra, a prescription drug, is manufactured in various forms such as Injection. It is typically used for the treatment of Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia. Secondary and off-label uses of Mabtas Ra have also been mentioned below.
The optimal dosage of Mabtas Ra is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Common side effects of Mabtas Ra include Weakness. Some other side effects of Mabtas Ra have been listed ahead. Usually, these side effects of Mabtas Ra go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Mabtas Ra has a Moderate effect for pregnant women and Severe effect on lactating mothers. Warnings related to Mabtas Ra's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Hyperkalemia must refrain from the use of Mabtas Ra since this can cause severe adverse effects. Some other conditions that can be affected by Mabtas Ra are listed in the contraindications section below.
Drug interactions for Mabtas Ra have been reported in the medical literature. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Mabtas Ra is considered not safe while driving, and is not addictive.
Mabtas Ra is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Mabtas Ra safe for pregnant women?
Mabtas RA may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Mabtas RA again without your doctor's advice.
Is the use of Mabtas Ra safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Mabtas RA. So it is adviced to consult the doctor before using it.
What is the effect of Mabtas Ra on the Kidneys?
Mabtas RA may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Mabtas Ra on the Liver?
Using Mabtas RA does not have any harmful effects on the liver.
What is the effect of Mabtas Ra on the Heart?
There may be an adverse effect on the heart after taking Mabtas RA. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
Mabtas Ra should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Mabtas Ra unless your doctor advises you to do so -
Is this Mabtas Ra habit forming or addictive?
No, there is no any evidence that Mabtas Ra is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Mabtas Ra can make you feel drowsy.
Is it safe?
Yes, but take Mabtas Ra only as per medical advice.
Is it able to treat mental disorders?
Mabtas Ra is unable to treat or cure mental disorders.
Interaction between Food and Mabtas Ra
It is safe to take Mabtas Ra with food.
Interaction between Alcohol and Mabtas Ra
Information about the interaction of Mabtas Ra and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rituxan (rituximab)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1106-1109
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872